Works by Wen, Xiaofeng


Results: 31
    1
    2
    3
    4
    5

    Identification of an intraocular microbiota.

    Published in:
    Cell Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41421-021-00245-6
    By:
    • Deng, Yuhua;
    • Ge, Xiaofei;
    • Li, Yan;
    • Zou, Bin;
    • Wen, Xiaofeng;
    • Chen, Weirong;
    • Lu, Lin;
    • Zhang, Meifen;
    • Zhang, Xiaomin;
    • Li, Chunmei;
    • Zhao, Chan;
    • Lin, Xiaofeng;
    • Zhang, Xiulan;
    • Huang, Xinhua;
    • Li, Xiaorong;
    • Jin, Ming;
    • Peng, Guang-Hua;
    • Wang, Dongni;
    • Wang, Xun;
    • Lai, Weiyi
    Publication type:
    Article
    6

    Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 9, p. 1134, doi. 10.1111/apt.16611
    By:
    • Liu, Zhihong;
    • Jin, Qinglong;
    • Zhang, Yuexin;
    • Gong, Guozhong;
    • Wu, Guicheng;
    • Yao, Lvfeng;
    • Wen, Xiaofeng;
    • Gao, Zhiliang;
    • Huang, Yan;
    • Yang, Daokun;
    • Chen, Enqiang;
    • Mao, Qing;
    • Lin, Shide;
    • Shang, Jia;
    • Gong, Huanyu;
    • Zhong, Lihua;
    • Yin, Huafa;
    • Wang, Fengmei;
    • Hu, Peng;
    • Xiao, Ling
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single‐arm, open‐label, phase 3 trial.

    Published in:
    Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 9, p. 2375, doi. 10.1111/jgh.15412
    By:
    • Kong, Fei;
    • Wen, Xiaoyu;
    • Wen, Xiaofeng;
    • Wang, Xiaozhong;
    • Wu, Guicheng;
    • Lin, Shide;
    • Wang, Li;
    • Xing, Huichun;
    • Yan, Xuebing;
    • Zheng, Sujun;
    • Ning, Qin;
    • Wang, Zheng;
    • Zhang, Liaoyun;
    • Lin, Jianmei;
    • Tong, Zhaowei;
    • Huang, Chengyu;
    • Su, Minghua;
    • Tong, Lixin;
    • Jia, Jidong;
    • Xin, Yongning
    Publication type:
    Article
    14
    15
    16
    17
    18

    Author Correction: Identification of an intraocular microbiota.

    Published in:
    2024
    By:
    • Deng, Yuhua;
    • Ge, Xiaofei;
    • Li, Yan;
    • Zou, Bin;
    • Wen, Xiaofeng;
    • Chen, Weirong;
    • Lu, Lin;
    • Zhang, Meifen;
    • Zhang, Xiaomin;
    • Li, Chunmei;
    • Zhao, Chan;
    • Lin, Xiaofeng;
    • Zhang, Xiulan;
    • Huang, Xinhua;
    • Li, Xiaorong;
    • Jin, Ming;
    • Peng, Guang-Hua;
    • Wang, Dongni;
    • Wang, Xun;
    • Lai, Weiyi
    Publication type:
    Correction Notice
    19

    Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.

    Published in:
    Infectious Diseases & Therapy, 2023, v. 12, n. 11, p. 2595, doi. 10.1007/s40121-023-00872-4
    By:
    • Hua, Rui;
    • Kong, Fei;
    • Li, Guangming;
    • Wen, Xiaofeng;
    • Zhang, Yuexin;
    • Yang, Xingxiang;
    • Meng, Chenxin;
    • Xie, Wen;
    • Jiang, Yongfang;
    • Wang, Xiaozhong;
    • Han, Xueji;
    • Huang, Yan;
    • Mao, Qing;
    • Wang, Jiefei;
    • Guan, Yujuan;
    • Chen, Jiayu;
    • Ma, Yingjie;
    • Xiong, Qingfang;
    • Ma, Hong;
    • Yan, Xuebing
    Publication type:
    Article
    20

    Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open‐label, phase 2 study.

    Published in:
    Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 455, doi. 10.1111/jvh.13650
    By:
    • Hua, Rui;
    • Kong, Fei;
    • Wen, Xiaofeng;
    • Xiong, Qingfang;
    • Chen, Jiayu;
    • Meng, Chenxin;
    • Ma, Hong;
    • Tan, Youwen;
    • Huang, Yan;
    • Jiang, Yongfang;
    • Guan, Yujuan;
    • Mao, Xiaorong;
    • Wang, Jiefei;
    • Xin, Yongning;
    • Gao, Hainv;
    • Xu, Bin;
    • Li, Cheng;
    • Wu, Qiong;
    • Zhang, Xian;
    • Wang, Zhiqiang
    Publication type:
    Article
    21
    22
    23
    24

    Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single‐arm, open‐label, phase 3 trial.

    Published in:
    Liver International, 2020, v. 40, n. 11, p. 2685, doi. 10.1111/liv.14633
    By:
    • Gao, Yanhang;
    • Kong, Fei;
    • Li, Guangming;
    • Li, Cheng;
    • Zheng, Sujun;
    • Lin, Jianmei;
    • Wen, Xiaofeng;
    • Hu, Jinghua;
    • Wang, Xiaozhong;
    • Wu, Xiaofeng;
    • Xing, Huichun;
    • Jia, Jidong;
    • Jia, Zhansheng;
    • Guan, Yujuan;
    • Li, Chenghao;
    • Wu, Guicheng;
    • Gao, Zhiliang;
    • Mou, Zhuangbo;
    • Ning, Qin;
    • Mao, Qing
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31